Phase 4 N=711 RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=53 Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
Pain · Pain, Acute · Anesthesia
Primary: Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival — 4; 4 score on a scale
Phase 4 N=82 Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies
Coronary Artery Disease · Peripheral Arterial Disease · Atrial Fibrillation
Primary: Platelet-Mediated Global Thrombogenicity — 66; 59; 69; 71 percentage of aggregation — p=0.275
Phase 4 N=91 A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™
Hepatitis B
Primary: Seroprotection Rate Achieved One Month After the Third Immunization With Sci-B-Vac™. — 83 Participants
Phase 4 N=21 Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
Evaporative Dry Eye
Primary: Tear Evaporation Rate — 1.15; 1.38; 1.26; 1.32 % relative humidity per second — p=0.002
Phase 4 N=102 Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler
Post-operative Pain Management
Primary: Post-Operative Pain — 49.4; 56.6 units on a Visual Analog Scale (VAS)
Phase 4 N=100 TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Psychiatric Emergency · Aggression · Agitation
Primary: Number of Participants According to the Time Taken for Aggressive Behaviour to Change to Calm and Tranquil — 18; 14; 41; 25 participants
Phase 4 N=59 Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
Rabies
Primary: Protective Humoral Immune Response at 1 Month Post First Vaccination. — 12; 12; 12; 11 Participants
Phase 4 N=70 Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen
Cataract
Primary: Change From Baseline (Preoperative Exam) in Macular Thickness — 4.91; 1.30 microns
Phase 4 N=50 Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Severe Hemophilia A
Primary: Number of Participants With Factor VIII (FVIII) Inhibitor Development — 0 Participants
Phase 4 N=40 Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
Gestational Diabetes Mellitus
Primary: Hemoglobin A1C — 5.5; 5.6 A1c percent
Phase 4 N=217 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
Coronary Artery Disease · Carotid Artery Diseases · Atherosclerosis
Primary: Annualized LRNC Volume Change in Carotid Plaque Composition, as Assessed by MRI — -4.6; -15.1; -9.4 mm^3/year
Phase 4 N=106 PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
Bleeding · Blood Loss, Surgical · Cardiovascular Surgical Procedures
Primary: Chest Tube Output — 1022; 937 mL — p=0.84
Phase 4 N=70 Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery
Analgesia, Obstetrical · Postpartum Hemorrhage · Opioid Use
Primary: Estimated Blood Loss (EBL) — 900; 800 ml — p=0.34
Phase 4 N=309 Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients
Dyspepsia
Primary: Changes in Severity of Functional Dyspepsia Symptoms — 10.1; 10.0; 5.1; 5.2 score on a scale — p=0.041